A phase II study single agent of aflibercept (VEGF Trap) in patients with recurrent or metastatic gynecologic carcinosarcomas and uterine leiomyosarcoma. A trial of the Princess Ma...

Por Mackay, HJ, Buckanovich, RJ, Hirte, H, Correa, R, Hoskins, P, Biagi, J, Martin, LP, Fleming, GF, Morgan, R, Wang, L, Polintan, R, Oza, AM
Publicado em 2011